BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Diagnosis
7258 results:

  • 1. Therapeutic Choices in Patients with Ph-Positive Chronic Myelogenous leukemia In Mexico in the Era of Tyrosine Kinase Inhibitors: Stem Cell Transplantation or Tyrosine Kinase Inhibitors? Fifteen Years Later.
    Max RN; Daniela SB; Moisés M GP; Edgar J HF; Merittzel A MR; María de L PM; Juan C OG; Guillermo J RD; Guillermo J RA
    Rev Invest Clin; 2024; 76(2):91-96. PubMed ID: 38740380
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Philadelphia chromosome-positive acute myeloid leukemia successfully treated by allogeneic hematopoietic stem cell transplantation: A case report and review of the literature.
    Zhang Z; Wang X; Bai J; Yang X; Lian B; Zhang Y; Kang J; Pan Y
    Medicine (Baltimore); 2024 May; 103(19):e38110. PubMed ID: 38728478
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study].
    Zhang XS; Liu BC; Du X; Zhang YL; Xu N; Liu XL; Li WM; Lin H; Liang R; Chen CY; Huang J; Yang YF; Zhu HL; Pan L; Wang XD; Li GH; Liu ZG; Zhang YQ; Liu ZF; Hu JD; Liu CS; Li F; Yang W; Meng L; Han YQ; Lin LE; Zhao ZY; Tu CQ; Zheng CF; Bai YL; Zhou ZP; Chen SN; Qiu HY; Yang LJ; Sun XL; Sun H; Zhou L; Liu ZL; Wang DY; Guo JX; Pang LP; Zeng QS; Suo XH; Zhang WH; Zheng YJ; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):215-224. PubMed ID: 38716592
    [No Abstract]    [Full Text] [Related]  

  • 4. Hopelessness and Social Support among Cancer Patients in Saudi Arabia.
    Rawas H; De Beer J; Alturki O; Altorki M; Alhelali T; Althagfi A; Faisal N; Albalawi F; Khan MA
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1363-1370. PubMed ID: 38679998
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mycosis fungoides with large cell transformation (CD30+) and B-cell chronic lymphocytic leukemia.
    Petković M; Ilić I; Jurakić Tončić R; Radman-Livaja I; Čeović R
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):223-224. PubMed ID: 38651850
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Recurrent Marginal Zone Lymphoma with Bone Marrow Involvement Detected by ¹⁸F-FDG PET/CT and Biopsy: A Diagnostic Challenge.
    Hsiao YS; Shen SC; Hsiao SC
    Am J Case Rep; 2024 Apr; 25():e943275. PubMed ID: 38644602
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases.
    Zhang LF; Zhang Y; Shui RH; Lu HF; Jiang WH; Cai X; Li XQ; Yu BH
    Diagn Pathol; 2024 Apr; 19(1):60. PubMed ID: 38627702
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Neuropsychological task outcomes among survivors of childhood acute lymphoblastic leukemia in Malaysia.
    Alias H; Mohd Ranai N; Lau SCD; de Sonneville LMJ
    Sci Rep; 2024 Apr; 14(1):7915. PubMed ID: 38575744
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Discontinuation of tyrosine kinase inhibitors before epiphyseal closure leading to improved short stature in pediatric chronic myelogenous leukemia].
    Fukui W; Ogura T; Azumi S; Ogata H; Kawaguchi K; Takachi T; Horikoshi Y; Uematsu A; Shimada H; Watanabe K
    Rinsho Ketsueki; 2024; 65(3):175-179. PubMed ID: 38569862
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mental Health Care Utilization Among Parents of Children With Cancer.
    Hu X; Grosse SD; Han X; Marchak JG; Ji X
    JAMA Netw Open; 2024 Apr; 7(4):e244531. PubMed ID: 38564218
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Splenic B-cell lymphoma/leukemia with prominent nucleoli: A three-case series of the newly named old entity and review of literature.
    Rai V; Saha A; Gondha S; Manimaran P; Sawhney J
    J Cancer Res Ther; 2024 Jan; 20(1):315-320. PubMed ID: 38554340
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction: a single-centre, single-arm, phase 2 trial.
    Bazinet A; Kantarjian H; Bataller A; Pemmaraju N; Borthakur G; Chien K; Alvarado Y; Bose P; Jabbour E; Yilmaz M; DiNardo C; Issa G; Montalban-Bravo G; Short N; Sasaki K; Bull-Linderman D; Daver N; Garcia-Manero G; Ravandi F; Kadia T
    Lancet Haematol; 2024 Apr; 11(4):e287-e298. PubMed ID: 38548404
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Acute Lymphoblastic leukemia With Near-haploid Karyotype and Philadelphia Chromosome.
    Panagopoulos I; Andersen K; Wik HS; Tandsæther MR
    Anticancer Res; 2024 Apr; 44(4):1389-1397. PubMed ID: 38537997
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Incidence, risk factors, and outcome of asymptomatic central nervous system involvement in adult patients with acute myeloid leukemia.
    Virijevic M; Kraguljac-Kurtovic N; Mitrovic M; Jakovic L; Bukumuric Z; Pantic N; Sabljic N; Pravdic Z; Cvetkovic M; Knezevic V; Dragovic-Ivancevic T; Djunić I; Rajic J; Milosevic V; Todorovic-Balint M; Vidovic A; Suvajdzic-Vukovic N
    Hematol Oncol; 2024 Mar; 42(2):e3253. PubMed ID: 38536200
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Use of the ETV6/RUNX1 probe to verify the performance of the fluorescence in situ hybridization probe before clinical detection].
    Xiao J; Zheng YC; Zhao JW; Cui CH; Wang HJ; Sun Q; Ma J; Ma YS; Song Z; Xiao ZJ; Li CW
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):48-53. PubMed ID: 38527838
    [No Abstract]    [Full Text] [Related]  

  • 16. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
    Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
    [No Abstract]    [Full Text] [Related]  

  • 17. Evaluation of childhood malignancies presenting with musculoskeletal manifestations from two different divisions: a multicenter study.
    Çağlayan Ş; Koç BŞ; Baba Ö; Bağlan E; Kurucu B; Yıldırım DG; Ayhan AC; Çakan M; Yener GO; Öztürk K; Çakmak F; Sönmez HE; Ayaz NA; Kısaarslan AP; Bakkaloğlu S; Kalyoncu M; Kılıç SÇ; Sözeri B
    Turk J Pediatr; 2024; 66(1):81-89. PubMed ID: 38523382
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The effect of pregnancy on renal angiomyolipoma; a world of knowledge to gain, specifically in women with TSC.
    Kluiving MW; Peeters EFHI; Lely TA; van Oorschot N; de Ranitz-Greven WL
    BMC Nephrol; 2024 Mar; 25(1):113. PubMed ID: 38519911
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic era.
    Iat A; Loschi M; Benachour S; Calleja A; Chiche E; Sudaka I; Aquaronne D; Ferrero C; Fenwarth L; Marceau A; Fournier E; Dadone-Montaudie B; Cluzeau T
    Cancer Med; 2024 Mar; 13(6):e7103. PubMed ID: 38506267
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Noise suppression of proton magnetic resonance spectroscopy improves paediatric brain tumour classification.
    Zhao T; Grist JT; Auer DP; Avula S; Bailey S; Davies NP; Grundy RG; Khan O; MacPherson L; Morgan PS; Pizer B; Rose HEL; Sun Y; Wilson M; Worthington L; Arvanitis TN; Peet AC
    NMR Biomed; 2024 Jun; 37(6):e5129. PubMed ID: 38494431
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 363.